What You Should Know:
– Cognoa, a pediatric behavioral health company appoints Dr. Sharief Taraman as Chief Executive Officer. Dr. Taraman previously served as Cognoa’s Chief Medical Officer and brings nearly two decades of clinical specialization in neurodevelopmental conditions, clinical informatics, and business acumen.
– Dr. Taraman served as the company’s Chief Medical Officer since 2017, leading clinical evidence generation and regulatory milestones of Canvas Dx and those resulting in FDA Breakthrough Device Designation of Cognoa’s autism digital therapeutic.
– Dr. Taraman brings the strategic vision and exceptional ability to accelerate Cognoa’s development of its extensible AI platform and product pipeline targeting multiple behavioral health conditions including autism, speech and language, ADHD, and childhood anxiety.
